Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Poplack

Showing results (221-230 of 227) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 227 results.
Cancer Research|April 15, 1988
A pediatric phase I and pharmacokinetic study of spirohydantoin mustardR L Heideman, J A Kelley, R J Packer, et al.
The Journal of Clinical Investigation|February 1, 1983
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor originsS J Korsmeyer, A Arnold, A Bakhshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
The American Journal of Medicine|August 1, 1979
Duration of empiric antibiotic therapy in granulocytopenic patients with cancerP A Pizzo, K J Robichaud, F A Gill, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Pageof 23

Showing results (221-230 of 227) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 227 results.
Cancer Research|April 15, 1988
A pediatric phase I and pharmacokinetic study of spirohydantoin mustardR L Heideman, J A Kelley, R J Packer, et al.
The Journal of Clinical Investigation|February 1, 1983
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor originsS J Korsmeyer, A Arnold, A Bakhshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
The American Journal of Medicine|August 1, 1979
Duration of empiric antibiotic therapy in granulocytopenic patients with cancerP A Pizzo, K J Robichaud, F A Gill, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Pageof 23